AANS Neurosurgeon | Volume 26, Number 3, 2017

Advertisement

Biomarker Breatkthrough Could Improve Parkinson's Treatment

A new, non-invasive way to track the progression of Parkinson’s disease could help evaluate experimental treatments to slow or stop the disease’s progression. University of Florida researchers used functional magnetic resonance imaging to reveal areas where Parkinson’s disease and related conditions cause progressive decline in brain activity. While currently treatments focus on controlling symptoms, biomarkers provide a quantifiable way to measure how medications address not just symptoms, but the neurological changes behind them. To read more, click here.

Comments are closed.